- Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations Gallery
Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations
Singapore | HSA Updates Post-Marketing Vigilance Requirements for Therapeutic Products and CTGTPs — Expanding Lifecycle Pharmacovigilance and Safety Reporting Expectations
Please login to view this page.
Canada | Health Canada Expands Lifecycle Oversight of Medical Devices Through New Guidance Framework
Please login to view this page.
Brazil | Major Reform of National Research Ethics Oversight Advances Through New INAEP Governance Framework and Regulatory Actions
Please login to view this page.
CANADA | CDA Draft Guidance Expands Economic Evaluations to Include Caregiver and Productivity Impacts
Please login to view this page.
BRAZIL | Ministry of Health Continues Implementation of Law 14,874/2024 Through Governance Appointments and Platform Oversight Measures
Please login to view this page.
UK | Proportionate Approval Route Introduced for Studies Involving NHS Staff as Research Participants
Please login to view this page.
UK | HRA Advances Digital Transformation of Non-CTIMP Approvals with User-Centred Design Approach
Please login to view this page.
EU | EMA Publishes New GVP Module on Pregnancy and Breastfeeding — Implications for Real-World Safety Research
Please login to view this page.
EU | EMA Proposes Revision of Good Pharmacogenomic Practice Guideline to Reflect Scientific Advances
Please login to view this page.










